Has David Chu received payments from drug or device companies?

Yes. Drug and device makers reported $64,542 in general payments to David Chu across 104 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Chu did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Chu come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Chu

Dermatology · San Diego, CANPI 1982765525

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $48,420 of the $64,542 with a category attached, or 75.0%. Sanofi accounts for 69.0% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $64,401 and has fallen 100.0% since, to $21 in 2024. Among dermatology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$64,542in general payments, 2019–2025

Across 104 payments — averaging $620.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$45K
Regeneron$10K
Regeneron Healthcare Solutions, Inc.$7K
UCB, Inc.$1K
Promius Pharma LLC$500
Lilly USA, LLC$469
plus $894 from 13 others

What the payments were for

Consulting fees$9,17014%
Speaking & faculty fees$48,42075%
Travel & lodging$4,5727%
Food & beverage$2,3504%
Education$300%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	34	$44,534
Regeneron	15	$9,562
Regeneron Healthcare Solutions, Inc.	18	$7,260
UCB, Inc.	3	$1,323
Promius Pharma LLC	1	$500
Lilly USA, LLC	9	$469
Sanofi-aventis U.S. LLC	4	$358
AbbVie	1	$120
Pfizer	6	$108
Janssen Research & Development, LLC	1	$70
Dermira, Inc.	2	$37
EPI Health, LLC	1	$31
LEO Pharma Inc.	1	$30
Johnson & Johnson	1	$29
Novartis	2	$25
Taro Pharmaceuticals USA, Inc.	1	$25
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$23
Mindray DS USA, Inc.	1	$21
Sun Pharmaceutical Industries Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$64,542 in reported general payments places this provider in the 90th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California →

Other dermatology in San Diego

Neal BhatiaSan Diego$2.5M
Arisa OrtizSan Diego$261K
Michael BradshawSan Diego$143K
Paul YamauchiSanta Monica$2.9M
Jennifer SoungSanta Ana$2.8M
Robert GreenbergLivermore$2.6M
April ArmstrongLos Angeles$2.3M
Jeffrey CrowleyBakersfield$2.1M
Jashin WuCorona$2M
Raja SivamaniSacramento$1.9M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →